Jonathan Jay Mazelsky - President and CEO, Director at Idexx Laboratories Inc /De

Insider Transactions and Holdings

Entity Type
Individual
Role
President and CEO, Director
Stock Symbol
IDXX on Nasdaq
Industry
In Vitro & In Vivo Diagnostic Substances
All Insider Reports
All Insider Reports

Jonathan Jay Mazelsky - trading volume in the past year for Idexx Laboratories Inc /De

Holdings reported by Jonathan Jay Mazelsky for Idexx Laboratories Inc /De

Class Num Shares Value Price $ Report Date Ownership Underlying Class Underlying Amount
Common Stock 81,497 $16.9 M $206.94 Feb 29, 2024 Direct
Restricted Stock Unit 3,298 $1.85 M $560.56 Feb 14, 2024 Direct Common Stock
Non-Qualified Stock Option (right-to-buy) 21,335 Feb 14, 2024 Direct Common Stock
Incentive Stock Option (right-to-buy) 0 Feb 21, 2024 Direct Common Stock

Transactions reported by Jonathan Jay Mazelsky for Idexx Laboratories Inc /De

Sym Class Transaction % Value $ Price $ Shares Shares After Date Ownership